Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K1 | Q92918 | 7/20 | 0.81 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.35 |
| ▸ | JAK2 | O60674 | 2/20 | 0.35 |
| ▸ | JAK1 | P23458 | 2/20 | 0.35 |
| ▸ | TYK2 | P29597 | 2/20 | 0.35 |
| ▸ | JAK3 | P52333 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.35 |
| ▸ | PAK1 | Q13153 | 2/20 | 0.34 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.34 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22858777 | 1.00 | MAP4K1 (0.81) | MAP4K1PIK3CGJAK2JAK1TYK2 | |
| SCHEMBL29609219 | 1.00 | MAP4K1 (0.81) | MAP4K1PIK3CGJAK2JAK1TYK2 | |
| SCHEMBL29608396 | 1.00 | MAP4K1 (0.81) | MAP4K1PIK3CGJAK2JAK1TYK2 | |
| SCHEMBL22858867 | 1.00 | MAP4K1 (0.81) | MAP4K1PIK3CGJAK2JAK1TYK2 | |
| SCHEMBL22858708 | 0.94 | MAP4K1 (0.81) | MAP4K1PIK3CGJAK2JAK1TYK2 | |
| SCHEMBL29608998 | 0.94 | MAP4K1 (0.81) | MAP4K1PIK3CGJAK2JAK1TYK2 | |
| SCHEMBL22858775 | 0.94 | MAP4K1 (0.81) | MAP4K1PIK3CGJAK2JAK1TYK2 | |
| SCHEMBL22858869 | 0.94 | MAP4K1 (0.81) | MAP4K1PIK3CGJAK2JAK1TYK2 | |
| SCHEMBL29608121 | 0.94 | MAP4K1 (0.81) | MAP4K1PIK3CGJAK2JAK1TYK2 | |
| SCHEMBL22858872 | 0.93 | MAP4K1 (0.70) | MAP4K1PIK3CGJAK2JAK1TYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021000925-A1 | PYRROLO [2, 3-b] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF | BEIGENE, LTD. (KY) | 2021-01-07 | — | — | WO | disclosed |